[A new therapeutic approach of associated metabolic diseases. 1 000 patients treated with benfluorex (author's transl)].
Multiple metabolic factors of atherosclerosis frequently associated in the same patient proves the interest of a multifactorial treatment of atherosclerosis. In the paper the authors studied the results of the treatment with benfluorex of 1 000 patients suffering one or more metabolic risk factors. After a 3 month treatment, a highly significant and simultaneous reduction of hyperlipidemia, hyperglycemia, hyperuricemia is observed. The treatment is the more efficient that initial values are higher and that the diet is better observed. The results remain significant even in patients who have not lost weight.
D001161:Arteriosclerosis / Q000517:prevention & control; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D005277:Fenfluramine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008659:Metabolic Diseases / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides; D014527:Uric Acid; D005277:Fenfluramine; C001584:benfluorex; D002784:Cholesterol
Une nouvelle approche thérapeutique des polysurcharges métaboliques. A propos de mille malades traités par le benfluorex.